CEL-SCI

AMEX CVM
$1.48 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 12 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

71.74M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

69.56M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

2.18
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

48.47M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-45.59 %

Upcoming events CEL-SCI

All events
No upcoming events scheduled

Stock chart CEL-SCI

Stock analysis CEL-SCI

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-2.30 -1.10
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
5.43 1.87
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-2.64 -0.65
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.08 0.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-246.77 -87.14

Price change CEL-SCI per year

7.08$ 27.89$
Min Max

Summary analysis CEL-SCI

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure CEL-SCI

Revenue and net income CEL-SCI

All parameters

Stock news CEL-SCI

All news

CEL-SCI Slides After Follow-on Offering Prices Below Market Price

CEL-SCI Slides After Follow-on Offering Prices Below Market Price

CEL-SCI Shares Surge 36% on UK Evaluation of Cancer Treatment Multikine

CEL-SCI Shares Surge 36% on UK Evaluation of Cancer Treatment Multikine

CEL-SCI Shares Sink on $2/Share Offering Price

CEL-SCI Shares Sink on $2/Share Offering Price

CEL-SCI Shares Slide Premarket After Public Offering Priced >CVM

CEL-SCI Shares Slide Premarket After Public Offering Priced >CVM

Stocks to Watch: FB Financial, Masimo, Acumen Pharmaceuticals, CEL-SCI, Karyopharm Therapeutics

Stocks to Watch: FB Financial, Masimo, Acumen Pharmaceuticals, CEL-SCI, Karyopharm Therapeutics

CEL-SCI Shares Sink 20% After Stock Offering

CEL-SCI Shares Sink 20% After Stock Offering

CEL-SCI Reports Productive Meeting with FDA on Cancer Treatment

CEL-SCI Reports Productive Meeting with FDA on Cancer Treatment

CEL-SCI Shares Rise 14% After Meeting With Health Canada About Multikine

CEL-SCI Shares Rise 14% After Meeting With Health Canada About Multikine

CEL-SCI Shares Retreat 11% After Big Rise Monday

CEL-SCI Shares Retreat 11% After Big Rise Monday

CEL-SCI Shares Rise 51% With High Volume

CEL-SCI Shares Rise 51% With High Volume

About company CEL-SCI

CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Address:
8229 Boone Boulevard, Vienna, VA, United States, 22182
Company name: CEL-SCI
Issuer ticker: CVM
ISIN: US1508376076
Country: USA
Exchange: AMEX
Currency: $
IPO date: 1987-01-01
Sector: Healthcare
Industry: Biotechnology
Site: https://cel-sci.com

On which stock exchange are CEL-SCI (CVM) stocks traded?

CEL-SCI (CVM) stocks are traded on AMEX.

What is the ticker of CEL-SCI stocks (CVM)?

The stock ticker of CEL-SCI’s stocks or in other words, the code is CVM. The stocks are currently listed on the AMEX exchange.

In which sector and industry does CEL-SCI (CVM) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, CEL-SCI (CVM) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are CEL-SCI (CVM) stocks traded?

CEL-SCI (CVM) stocks are traded on the AMEX exchange in dollars.

What is the price of CEL-SCI (CVM) stocks today?

The current price of CEL-SCI stocks on 04.05.2024 is 1.48 dollars. per share.

What is the dynamics of CEL-SCI (CVM) stocks from the beginning of the year?

CEL-SCI (CVM) quotes have increased by -44.98% from the beginning of the year up to 1.48 dollars. per 1 stocks.

How much did CEL-SCI (CVM) stocks increase in мае 2024?

This month CEL-SCI (CVM) quotes have increased by 4.23% to 1.48 dollars. per share.

How much are CEL-SCI (CVM) stocks worth?

Today, on October, 04.05.2024 CEL-SCI’s (CVM) stocks cost 1.48 dollars..

What is the market capitalization of CEL-SCI (CVM)?

Capitalization is the market value of CEL-SCI (CVM) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 04.05.2024, the market capitalization of CEL-SCI (CVM) is estimated at about 71736488 dollars.